Predicting time to serologic diagnosis of AQP4+NMOSD based on clinical factors and social determinants of health
Background: Early serologic diagnosis and initiation of targeted therapy are associated with better outcomes in aquaporin-4 IgG positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD). Objective: To determine predictors of time to serologic diagnosis of AQP4+NMOSD. Methods: In CANOPTICS, a multi-centre, Canadian cohort study of NMOSD, we retrospectively evaluated time from the first clinical attack to…







